ARTICLE | Clinical News
ALKS 3831: Phase I data
January 21, 2013 8:00 AM UTC
A double-blind, placebo- and active-controlled Phase I trial in 106 healthy volunteers showed that subjects receiving once-daily oral ALKS 3831 had significantly less mean weight gain from baseline to...